Skip to main content

Table 2 Epidemiological data a

From: Pirfenidone gel in patients with localized scleroderma: a phase II study

Patient Sex Age (yr) Time of evolution (yr) Previous treatment Type of scleroderma Size of smallest lesion (cm 2 ) Size of largest lesion (cm 2 ) Affected segments
1 F 47 10 Yes Linear 10.5 97.5 1
2 F 24 1.5 No Linear 1.5 17.5 1
3 F 77 3 Yes Generalized 1 412.5 6
4 F 66 6 Yes Generalized 2 255 5
5 F 54 3 Yes Generalized 31.5 448 3
6 F 29 3 Yes Circumscribed 360 765 2
7 F 21 10 Yes Circumscribed 45 52.2 1
8 M 31 8 No Circumscribed 0.48 7 1
9 M 39 3 Yes Generalized 0.25 136 13
10 F 46 2 Yes Circumscribed 12 22.5 1
11 M 51 <1 No Generalized 1 36 3
12 F 48 4 No Generalized 6 189 2
Mean NA 46.5 3 NA NA 4 116.75 2
Maximum NA 77 10 NA NA 360 765 13
Minimum NA 21 1.5 NA NA 0.25 7 1
  1. aThe patients were predominately female (75%) and had received previous treatment (67%), and one-half (50%) had the generalized type of the disease. NA, Not applicable.